Albuquerque / Atlanta / Lausanne / Ottawa / Bern / Brussels / Tbilisi / Paris / Stockholm / /
Company
SPIEZ LABORATORY / Sandia National Laboratories / Novartis Vaccines and Diagnostics / Bayer / HDR Architecture Inc. / Biocontainment International Consultants Pty Ltd / SECB / GE / Knudsen / Crucell Switzerland AG / CHUV / /
Country
United States / United Kingdom / Georgia / /
Event
General or Shareholder Meeting / /
Facility
Agrochemical Research Center / University of Manchester/UK T. Aspinall / Swedish Institute / National Institute of Public Health / Scientific Institute of Public Health / Imperial College / Institute of Virology / University of Manchester/UK E. Toolbox / University of Zürich/CH U. Pauli / /
IndustryTerm
biorisk management / imaging / /
OperatingSystem
L3 / /
Organization
Biomedical Primate Research Centre / Institute of Virology / National Institute of Public Health & Environment / Imperial College London / National Center for Disease Control / Scientific Institute of Public Health / Institute of Virology and Immunoprophylaxis / Public Health Agency of Canada / Swedish Institute for Communicable Disease Control / European Biosafety Association / S. Welby / Veterinary and Agrochemical Research Center / Salisbury / Georgian Biosafety Association / University of Manchester / University of Zürich / Health Protection Agency / Saffron Guild / L3 Lab / Riga Eastern Clinical University / /
Person
A. Della-Porta / B. Van Vaerenbergh / P. Meylan / Matthias Müller / Horst Posthaus / Philippe Stroot / Chris Collins / /
Microsoft Word - programme_2013_draft_feb_2013.docx